Drugs / Commercial TriValent Split Influenza Virus
last change Oct 2005 re-read 3 minutes ago

Commercial TriValent Split Influenza Virus

Vaccine

Developed for
influenza
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID)

Trials 1

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT00138398 Oct 2005 → ? influenza National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Commercial TriValent Split Influenza Virus ClinicalTrials.gov intervention name — accepted as the source's own label NCT00138398 ↗
Modality Vaccine “inactivated influenza vaccine” NCT00138398 ↗